Haumann Brett K
Chief Medical Officer at TBPH
- Sold, on record
- $1.3M
- Dollars the filings state
- Form 4 sales
- 4
- Latest Aug 21, 2020
- Form 144 notices
- 0
- Proposed sales
- Companies
- 1
- Filed as an executive or holder
Companies
- TBPHTheravance Biopharma, Inc.Chief Medical Officer
Sales by reason
0
Routine
0
Plan not stated
0
No plan
0
Unusual
Form 4 sales per month, last 12 months.
Timeline
- 1 Form 4 sale TBPHPlan not statedAug 19, 2016 2016
Sold 9,509 shares at $27.97 ($266k)
Haumann Brett K, SVP Clin Dev & Chief Med Ofc
Sold 4.6% of holdings ($5.8M position)197,391 shares leftFirst sale on recordFiling
- 2 Form 4 sale TBPHPlan not statedAug 25, 2016 +6 days
Sold 4,491 shares at $27.99 ($126k)
Haumann Brett K, SVP Clin Dev & Chief Med Ofc
Sold 2.3% of holdings ($5.4M position)188,293 shares leftFiling
- 3 Form 4 sale TBPHPlan not statedMar 7, 2017 +194 days
Sold 14,000 shares at $31.50 ($441k)
Haumann Brett K, SVP Clin Dev & Chief Med Ofc
Sold 7.9% of holdings ($5.6M position)163,471 shares leftFiling
- 4 Form 4 sale TBPHPlan not statedAug 21, 2020 +1263 days
Sold 25,000 shares at $18.29 ($457k)
Haumann Brett K, Chief Medical Officer
Sold 8.1% of holdings ($5.6M position)282,810 shares leftFirst sale on recordFiling
Every transaction
Loading transactions…
Sales and notices (4)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Aug 21, 2020 | Aug 24, 2020 | TBPH | Chief Medical Officer | Form 4 sale | 25,000 | $457k | 8.1% | Plan not stated | SEC |
| Mar 7, 2017 | Mar 8, 2017 | TBPH | SVP Clin Dev & Chief Med Ofc | Form 4 sale | 14,000 | $441k | 7.9% | Plan not stated | SEC |
| Aug 25, 2016 | Aug 25, 2016 | TBPH | SVP Clin Dev & Chief Med Ofc | Form 4 sale | 4,491 | $126k | 2.3% | Plan not stated | SEC |
| Aug 19, 2016 | Aug 23, 2016 | TBPH | SVP Clin Dev & Chief Med Ofc | Form 4 sale | 9,509 | $266k | 4.6% | Plan not stated | SEC |